Novo Nordisk A/S
novo nordisk, loss weight product
Eli Lilly strengthens its position in weight-loss drugs.
1 source·01/10, 19:26·barrons.com
Wegovy shows promise in obesity trial results.
1 source·01/10, 12:53·finviz.com
Novo Nordisk presents promising data on obesity therapies.
How Eli Lilly Just Extended Its Lead in the Weight-Loss Drug Market
finviz·barrons.com·01/10, 19:19
Novo Nordisk Reports Wegovy Liver Fat Reduction in Obesity Trial Analysis
finviz·finviz.com·01/10, 12:44
Eli Lilly stock rises on striking 23% weight loss in drug combo trial
finviz·yahoo.com·30/09, 14:59
3 sources·10/06, 18:03·yahoo.com
Parvus Asset Management builds stake in Novo Nordisk.
2 sources·10/06, 15:18·yahoo.com
Hims faces challenges in weight-loss drug market.
1 source·10/06, 12:40·yahoo.com
Activist investor accumulating stake, seeking CEO influence.
1 source·09/06, 23:18·yahoo.com
Activist investor reportedly accumulating stock in Novo Nordisk.
1 source·09/06, 23:18·finviz.com
Novo Nordisk faces hurdles in weight-loss market.
1 source·09/06, 18:30·yahoo.com
No significant news affecting Novo Nordisk's stock.
1 source·29/05, 19:16·yahoo.com
Tariff delay positively impacts Novo Nordisk's stock.
1 source·27/05, 15:16·yahoo.com
Adding Lilly's new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects.
finviz·marketwatch.com·30/09, 14:32
Novo Nordisk Study Reports Weight Loss After Patients Switch to Oral Wegovy
finviz·finviz.com·30/09, 12:28
Novo Nordisk Launches Long-Term Study of CagriSema for Weight Loss; Shares Rise
·yahoo.com·10/06, 17:16
Novo Nordisk Stock Climbs on Report of Activist Investor Parvus Building Stake
·yahoo.com·10/06, 15:11
Meet the New Group of Weight-Loss Drugs. The Industry Is Betting Big on Amylin.
·yahoo.com·29/05, 18:16